PR Newswire Clinical TrialsOriginal article
Physicians Choose OpenEvidence Over Every Other AI Chatbot Combined in Independent Stanford-Harvard Study of Clinical AI
Positive
AI Analysis
Summary
An independent Stanford-Harvard study (NOHARM) found that physicians chose OpenEvidence more frequently than ChatGPT, Claude, Gemini, and all other external AI chatbots combined when given unrestricted access to AI resources.
Importance:3/10
Sentiment:
0.80
AIclinical decision supportcompetitive positioningphysician adoptionStanford-Harvard study
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 20, 2026 1:32 PM